Prostate Cancer

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age or meeting country definition of adult
  • Have histologically or cytologically confirmed adenocarcinoma of the prostate
  • Have measurable metastatic disease
  • Have progressive disease at study entry
  • Have adequate organ and marrow function

You may NOT participate in this study if you:

  • Have received radiation therapy within 4 weeks of study start
  • Have known brain metastases or cranial epidural disease
  • Have prior nonhormonal therapy initiated for the treatment of mCRPC.
  • Have uncontrolled, significant intercurrent or recent illness
  • Have had major had surgery within 4 weeks of study start

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Road Bronx, NY 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org

 

PROCADE prostate cancer

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:
• Are a male at least 18 years of age or older
• Have histologically or cytologically confirmed adenocarcinoma of the prostate

You may not participate in this study if you:
• Have a history of another malignancy within the previous two years other than curatively treated non-melanomatous skin cancer
• Have used any other investigational agent within the past four weeks
• Have had a gastrointestinal disorder affecting absorption such as gastrectomy or active peptic ulcer disease within the last three months

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org

PROSTATE CANCER De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are a male at least 18 years of age
• Are able and willing to swallow and retain oral medication
• Consent to provide a FFPE tissue block
• Have Asymptomatic or mildly symptomatic form of prostate cancer

You may NOT participate in this study if you:
• Have received major surgery within 4 weeks of study start
• Have brain metastases, or spinal cord compression
• Have past medical history of interstitial lung disease, drug-induced interstitial lung disease, radiation pneumonitis
• Have clinically significant heart disease
• Have inadequate bone marrow reserve or organ function

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Rd, 5th floor Room # 503,
Bronx, NY-10461
Phone: (718) 405-8209
Email: MPORTES@MONTEFIORE.ORG

Metastatic Castration Resistant Prostate Cancer

People with Prostate Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have histologically or cytologically confirmed adenocarcinoma of the prostate
  • Have metastatic prostate cancer disease
  • Are surgically or medically castrated
  • Have had no prior treatment with cytotoxic chemotherapy
  • Demonstrate adequate organ function

You may NOT participate in this study if you:

  • Have known symptomatic brain metastases.
  • Have clinically significant cardiovascular disease
  • Have untreated or impending spinal cord compression
  • Have a severe concurrent disease, infection, or comorbidity
  • Have a history of seizure
  • Have had major surgery within 4 weeks
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or C

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Road, Bronx, New York 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org

Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:
• Are a male or female at least 18 years of age
• Have a diagnosis of prostate adenocarcinoma
• Are willing to provide an archival tumor tissue sample or a fresh tumor tissue sample
• Are able to swallow the study medication tablets whole
• Have allowed prior treatments for localized prostate cancer

You may NOT participate in this study if you:
• Have a history of adrenal dysfunction
• Have Received an investigational intervention (including investigational vaccines) or used an invasive investigational medical device within 30 days before the planned first dose
• Have active malignancies
• Have known immunodeficiency virus (HIV) infection, hepatitis B or C
• Have had major surgery ≤28 days prior

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Road Bronx, NY 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org

Biochemical recurrence of prostate cancer – Parexel #245597

People with prostate cancer are asked to participate in a research study being conducted by Queens Hospital Center.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age
  • Previously took ADT, should be discontinued at least 16 weeks prior to screening
  • Are a patient with history of localized prostate cancer with prior curative treatment
  • Have an elevated prostate-specific antigen (PSA)

You may NOT participate in this study if you:

  • Have prior medical condition that may compromise data collection
  • Are currently receiving ADT
  • Are planning to have an x-ray prior to PET scan
  • Are participating in a clinical trial within 30 days of administration

Contact Information
Linda Bulone, Study Coordinator
82-68 164th Street Room A541 Jamaica, NY 11432
Phone: (718) 883-3751
Fax: (718) 883-6295
Email: bulonel@nychhc.org

Newly diagnosed prostate cancer

People with newly diagnosed prostate cancer are asked to participate in a research study being conducted by NYC Health +Hospitals

You may be eligible to participate in this study if you:

  • Is a male more than 18 years of age
  • Have confirmed adenocarcinoma of the prostate

You may NOT participate in this study if you:

  • Currently or in the past received hormone therapy treatment for prostate cancer

Contact Information
Rayhana Dhulkifl, RN., Clinical Trial Manger
82-68 164th Street
Jamaica NY 11432
Phone: (718) 883-3797
Email:   DHULKIFR@nychhc.org

Men with Metastatic Prostate Cancer

Men with metastatic prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age or older
  • Have been diagnosed with Stage IV prostate cancer
  • Are willing to provide a saliva or blood sample for genomic analysis

Contact Information

Mary Portes, Study Coordinator
1695 Eastchester Road Bronx, NY 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org

 

19-08-346 / TX233891

Castration-Resistant Prostate Cancer

People with castration-resistant prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male least 18 years of age or older
  • Have histologically or cytologically confirmed adenocarcinoma of prostate

You may not participate in this study if you:

  • Have known metastatic brain or meningeal tumors
  • Have uncontrolled clinically significant hypertension
  • Have known immunodeficiency virus (HIV) infection, active viral hepatitis or chronic liver disease

Contact Information

Mary Portes, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: 718-405-8209
Email: mportes@montefiore.org

 

19-06-359 / TX233892

Advanced Prostate Cancer

People with advanced prostate cancer are asked to participate in a research study being conducted by White Plains Hospital.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age or older
  • Have documented evidence of metastatic castration resistant prostate cancer
  • Are able to swallow and retain oral medication

You may not participate in this study if you:

  • Have had major surgery (excluding placement of vascular access) within the past 4 weeks
  • Have had radiotherapy with a wide field of radiation within the past 4 weeks
  • Have active infection including hepatitis B, hepatitis C and human immunodeficiency virus

Contact Information

Joel Victor, Study Coordinator
2 Longview Avenue
White Plains, New York 10601
Phone: (914) 849-7591
Fax: (914) 681-2972
Email: jvictor1@wphospital.org

 

 

19-06-195 / TX228661

TALAPRO-2

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age or older, 20 years old if Japan
  • Have histologically or cytologically confirmed adenocarcinoma of the prostate without small cell or signet cell features

You may not participate in this study if you:

  • Have received investigational treatment in another clinical study within the past 4 weeks
  • Have had prior treatment with opioids for pain related to either primary prostate cancer or metastasis within the past 28 days
  • Have clinically significant cardiovascular disease

Contact Information

Mary Portes, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: 718-405-8209
Email: mportes@montefiore.org

 

19-06-268 / TX228665

Small Cell Neuroendocrine Prostate Cancer

People with small cell neuroendocrine prostate cancer are asked to participate in a research study being conducted by White Plains Hospital.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age or older
  • Have histologic evidence of small cell neuroendocrine prostate cancer

You may not participate in this study if you:

  • Have clinically significant cardiovascular disease
  • Have clinically significant uncontrolled pulmonary disease
  • Have known positive status for human immunodeficiency virus active or chronic Hepatitis B or Hepatitis C

Contact Information
Joel Victor, Study Coordinator
2 Longview Avenue
White Plains, New York 10601
Phone: (914) 849-7591
Email: jvictor1@wphospital.org